NASDAQ: HCM
Hutchmed Ltd Stock Ownership - Who owns Hutchmed?

Insider buying vs selling

Have Hutchmed Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when HCM insiders and whales buy or sell their stock.

HCM Shareholders

What type of owners hold Hutchmed Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Schroder Investment Management Group0.17%1,477,494$16.52MInstitution
Allianz Asset Management Gmbh0.10%837,475$9.36MInstitution
State Street Corp0.03%304,829$3.41MInstitution
Aia Group Ltd0.03%291,229$3.26MInstitution
Mg PLC0.03%255,468$2.86MInstitution
Weiguo Su0.03%237,063$2.65MInsider
Amundi0.03%232,246$2.60MInstitution
Renaissance Technologies LLC0.02%132,062$1.48MInstitution
Bnp Paribas Financial Markets0.01%106,504$1.19MInstitution
Edith Shih0.01%100,000$1.12MInsider

1 of 3

HCM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HCM0.49%0.06%
ANIP32.79%67.21%Net SellingNet Selling
BHC49.61%50.39%Net BuyingNet Selling
HROW29.01%70.99%Net SellingNet Buying
PBH69.21%30.79%Net SellingNet Selling

Hutchmed Stock Ownership FAQ

Who owns Hutchmed?

Hutchmed (NASDAQ: HCM) is owned by 0.49% institutional shareholders, 0.06% Hutchmed insiders, and 99.45% retail investors. Weiguo Su is the largest individual Hutchmed shareholder, owning 237,063.00 shares representing 0.03% of the company. Weiguo Su's Hutchmed shares are currently valued at $2.64M.

If you're new to stock investing, here's how to buy Hutchmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.